ICON Acquires Mapi Group

July 27, 2017

Applied Clinical Trials

ICON plc-a global provider of drug development solutions and services to the pharmaceutical, biotechnology, and medical device industries-announced it has acquired the patient-centered health outcomes research and commercialization company, Mapi Group.

Read the full release here

Related Content:

News